• 1. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615
• 2. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 3. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 4. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 5. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere

Introduction to 4-bromo-7-chloro-2-methylquinoline (CAS No. 1070879-51-4)

4-bromo-7-chloro-2-methylquinoline, identified by the Chemical Abstracts Service Number (CAS No.) 1070879-51-4, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical and chemical research. This compound belongs to the quinoline family, a class of molecules known for their broad spectrum of biological activities and utility in medicinal chemistry. The structural features of 4-bromo-7-chloro-2-methylquinoline, including the presence of bromine and chlorine substituents, make it a versatile scaffold for further chemical modifications and derivatization, which has opened up numerous possibilities in drug discovery and development.

The quinoline scaffold is a privileged structure in medicinal chemistry, with many clinically used drugs featuring this core moiety. Its aromatic system allows for interactions with various biological targets, including enzymes and receptors. The introduction of halogen atoms, such as bromine and chlorine, at specific positions on the quinoline ring enhances its reactivity and binding affinity, making it an attractive intermediate for synthesizing novel bioactive compounds.

In recent years, 4-bromo-7-chloro-2-methylquinoline has been extensively studied for its potential applications in the development of antimicrobial, anticancer, and anti-inflammatory agents. The bromine and chlorine atoms serve as handles for further functionalization via cross-coupling reactions, such as Suzuki-Miyaura and Buchwald-Hartwig couplings, which are widely employed in the synthesis of complex organic molecules. These reactions allow for the introduction of aryl or heteroaryl groups at various positions on the quinoline ring, leading to a diverse library of derivatives with tailored biological properties.

One of the most compelling aspects of 4-bromo-7-chloro-2-methylquinoline is its role as a precursor in the synthesis of kinase inhibitors. Kinases are enzymes that play crucial roles in cell signaling pathways, and their dysregulation is often associated with various diseases, particularly cancer. By designing analogs of 4-bromo-7-chloro-2-methylquinoline, researchers have been able to develop potent inhibitors that target specific kinases involved in tumor growth and progression. For instance, studies have shown that derivatives of this compound can inhibit tyrosine kinases, which are key players in signal transduction pathways that drive cancer cell proliferation.

The incorporation of both bromine and chlorine atoms into the quinoline ring provides multiple sites for selective functionalization, enabling the construction of highly complex molecular architectures. This flexibility has been exploited in the design of inhibitors targeting other therapeutic areas as well. For example, recent research has highlighted the potential of 4-bromo-7-chloro-2-methylquinoline derivatives as scaffolds for developing antiviral agents. The ability to modify the quinoline core through halogenation strategies allows for fine-tuning of interactions with viral proteases and polymerases, leading to compounds with improved efficacy against RNA viruses.

Another area where 4-bromo-7-chloro-2-methylquinoline has shown promise is in the development of anti-inflammatory agents. Chronic inflammation is a hallmark of many diseases, including arthritis and cardiovascular disorders. Quinoline derivatives have been reported to modulate inflammatory pathways by inhibiting key enzymes such as cyclooxygenase (COX) and lipoxygenase (LOX). The structural features of 4-bromo-7-chloro-2-methylquinoline make it an ideal candidate for designing molecules that can selectively inhibit these enzymes without causing significant side effects.

The synthesis of 4-bromo-7-chloro-2-methylquinoline itself is a testament to the advancements in organic chemistry methodologies. Modern synthetic routes involve multi-step processes that highlight the power of transition metal catalysis and palladium-mediated reactions. The ability to efficiently introduce bromine and chlorine atoms at desired positions on the quinoline ring relies on well-established protocols such as halogen exchange reactions and metal-catalyzed cross-coupling techniques. These methods ensure high yields and regioselectivity, which are critical for producing compounds suitable for further biological evaluation.

In conclusion, 4-bromo-7-chloro-2-methylquinoline (CAS No. 1070879-51-4) represents a valuable building block in pharmaceutical research due to its structural versatility and biological potential. Its role as a precursor in synthesizing kinase inhibitors, antiviral agents, and anti-inflammatory compounds underscores its importance in drug discovery efforts. As our understanding of biological targets continues to evolve, compounds like 4-bromo-7-chloro-2-methylquinoline will undoubtedly play a pivotal role in developing next-generation therapeutics that address unmet medical needs.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)